Dennis Ausiello

Dennis Arthur Ausiello currently works at Spexis Ltd., as Vice Chairman from 2021, TARIS BioMedical LLC, as Director from 2009, KinDex Pharmaceuticals, Inc., as Director, Alnylam Pharmaceuticals, Inc., as Independent Director from 2012, Research!America, as Director, Institute for Human Genetics & Research, as Director, Seres Therapeutics, Inc., as Independent Director from 2015, Rani Therapeutics LLC, as Director from 2018, EnBiotix, Inc., as Director, Rani Therapeutics Holdings, Inc., as Independent Director from 2018, Catch Health, Inc., as Director, National Academy of Sciences, as Member, American Academy of Arts & Sciences, as Member, National Academy of Medicine (United States), as Member, InCube Venture Partners LLC, as Board of Advisor, Harvard Medical School, as Professor-Clinical Medicine, and Institute of Medicine of The National Academies of Science, as Member.
Dr. Ausiello also formerly worked at Pfizer Inc., as Lead Independent Director from 2015 to 2019, Fraunhofer USA, Inc., as Director, The Broad Institute, Inc., as Director-Human Genetics, Tarveda Therapeutics, Inc., as Director, The General Hospital Corp., as Chief Medicine Officer from 1996 to 2011, Mass General Brigham, Inc., as Chief Scientific Officer from 1996 to 2013, and Association of American Physicians, as President.
Dr. Ausiello received his doctorate degree from the University of Pennsylvania and undergraduate degree from Harvard College.